About Max Dawson
Max Dawson is an executive officer at Rinascera Therapeutics.
Form D filings also name Max Dawson as an executive officer at DermBiont.
Max Dawson first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Max Dawson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Max Dawson works with at each company, as listed on that company's latest Form D.
Rinascera Therapeutics, Inc. · Form D, Oct 8, 2025
NE
Nichola Eliovits
Chief Executive Officer and director
DY
Daniel Yadegar
Director
KB
Karl Beutner
Executive officer and director
DermBiont, Inc. · Form D/A, Nov 13, 2024
DY
Daniel Yadegar
Director
SB
Steven Basta
Director
KB
Karl Beutner
Chief Executive Officer and director
NE
Nichola Eliovits
Executive officer and director
WR
Wilder Ramsey
Director